FINGOLIMOD ZENTIVA kõvakapsel Eesti - eesti - Ravimiamet

fingolimod zentiva kõvakapsel

zentiva k.s. - fingolimood - kõvakapsel - 0,5mg 56tk

FINGOLIMOD TEVA kõvakapsel Eesti - eesti - Ravimiamet

fingolimod teva kõvakapsel

teva gmbh - fingolimood - kõvakapsel - 0,5mg 30tk

FINGOLIMOD MEDOCHEMIE kõvakapsel Eesti - eesti - Ravimiamet

fingolimod medochemie kõvakapsel

medochemie limited - fingolimood - kõvakapsel - 0,5mg 98tk; 0,5mg 28tk; 0,5mg 7tk; 0,5mg 10tk; 0,5mg 30tk

EFIGALO kõvakapsel Eesti - eesti - Ravimiamet

efigalo kõvakapsel

krka, d.d., novo mesto - fingolimood - kõvakapsel - 0,5mg 90tk; 0,5mg 100tk

Fingolimod Mylan Euroopa Liit - eesti - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod vesinikkloriid - sclerosis multiplex, relapsing-remitting - immunosupressandid - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ja 5. 1)orpatients kiiresti arenev raske relapsing remitting sclerosis multiplex määratud 2 või enam puuet ägenemiste ühe aasta, ja on 1 või enam gadoliinium suurendada kahjustused aju mri või olulist kasvu, t2 kahjustus koormus võrreldes varasema hiljutise mrt.

INZOLFI kõvakapsel Eesti - eesti - Ravimiamet

inzolfi kõvakapsel

sandoz pharmaceuticals d.d. - fingolimood - kõvakapsel - 0,5mg 7tk

FINGOLIMOD RICHTER kõvakapsel Eesti - eesti - Ravimiamet

fingolimod richter kõvakapsel

gedeon richter plc. - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 98tk

Fingolimod Mylan Euroopa Liit - eesti - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod vesinikkloriid - sclerosis multiplex, relapsing-remitting - immunosupressandid - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ja 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

FINGOLIMOD STADA kõvakapsel Eesti - eesti - Ravimiamet

fingolimod stada kõvakapsel

stada arzneimittel ag - fingolimood - kõvakapsel - 0,5mg 7tk

FINGOLIMOD REMEDICA kõvakapsel Eesti - eesti - Ravimiamet

fingolimod remedica kõvakapsel

remedica limited - fingolimood - kõvakapsel - 0,5mg 7tk